FHIR Release 3 (STU)

This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3

V2-0477.cs.xml

Vocabulary Work Group Maturity Level: N/A Ballot Status: Informative

Raw XML (canonical form)

FHIR Value set/code system definition for HL7 v2 table 0477 ( Controlled Substance Schedule)

<CodeSystem xmlns="http://hl7.org/fhir"><id value="v2-0477"/><meta ><profile value="http://hl7.org/fhir/StructureDefinition/shareablecodesystem"/></meta><text ><status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><p >Controlled Substance Schedule</p><table class="grid"><tr ><td ><b >Code</b></td><td ><b >Description</b></td><td ><b >Comment</b></td><td ><b >Version</b></td></tr><tr ><td >I
 <a name="I"></a></td><td >Schedule I</td><td >Includes drugs that have a high potential for abuse, no currently accepted medical use
 in the United States and a lack of accepted safety for use under medical supervision.</td><td >added v2.5</td></tr><tr ><td >II
 <a name="II"></a></td><td >Schedule II</td><td >Includes drugs having currently accepted medical use in the United States and a high abuse
 potential, with severe psychological or physical dependence liability.</td><td >added v2.5</td></tr><tr ><td >III
 <a name="III"></a></td><td >Schedule III</td><td >Includes drugs having an abuse potential less than that of drugs listed in Schedules I
 and II. All CS III drugs have a currently accepted medical use in the United States.</td><td >added v2.5</td></tr><tr ><td >IV
 <a name="IV"></a></td><td >Schedule IV</td><td >Includes drugs having a lesser potential for abuse than those listed in Schedule III.
 CS IV drugs have a currently accepted medical use in the United States.</td><td >added v2.5</td></tr><tr ><td >V
 <a name="V"></a></td><td >Schedule V</td><td >Includes drugs having low abuse potential and limited physical or psychological dependence
 relative to those listed in IV and have an accepted medical use in the United States.</td><td >added v2.5</td></tr><tr ><td >VI
 <a name="VI"></a></td><td >Schedule VI</td><td >State defined</td><td >added v2.5</td></tr></table></div></text><extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-ballot-status"><valueString value="External"/></extension><extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"><valueInteger value="0"/></extension><url value="http://hl7.org/fhir/v2/0477"/><identifier ><system value="urn:ietf:rfc:3986"/><value value="urn:oid:2.16.840.1.113883.18.304"/></identifier><version value="2.8.2"/><name value="v2 Controlled Substance Schedule"/><status value="active"/><experimental value="false"/><publisher value="HL7, Inc"/><contact ><telecom ><system value="url"/><value value="http://hl7.org"/></telecom></contact><description value="FHIR Value set/code system definition for HL7 v2 table 0477 ( Controlled Substance Schedule)"/><caseSensitive value="false"/><valueSet value="http://hl7.org/fhir/ValueSet/v2-0477"/><content value="complete"/><concept ><extensionurl="http://hl7.org/fhir/StructureDefinition/codesystem-comments"><valueStringvalue="Includes drugs that have a high potential for abuse, no currently accepted medical use
 in the United States and a lack of accepted safety for use under medical supervision."/></extension><code value="I"/><display value="Schedule I"/></concept><concept ><extensionurl="http://hl7.org/fhir/StructureDefinition/codesystem-comments"><valueStringvalue="Includes drugs having currently accepted medical use in the United States and a high abuse
 potential, with severe psychological or physical dependence liability."/></extension><code value="II"/><display value="Schedule II"/></concept><concept ><extensionurl="http://hl7.org/fhir/StructureDefinition/codesystem-comments"><valueStringvalue="Includes drugs having an abuse potential less than that of drugs listed in Schedules I
 and II. All CS III drugs have a currently accepted medical use in the United States."/></extension><code value="III"/><display value="Schedule III"/></concept><concept ><extensionurl="http://hl7.org/fhir/StructureDefinition/codesystem-comments"><valueStringvalue="Includes drugs having a lesser potential for abuse than those listed in Schedule III.
 CS IV drugs have a currently accepted medical use in the United States."/></extension><code value="IV"/><display value="Schedule IV"/></concept><concept ><extensionurl="http://hl7.org/fhir/StructureDefinition/codesystem-comments"><valueStringvalue="Includes drugs having low abuse potential and limited physical or psychological dependence
 relative to those listed in IV and have an accepted medical use in the United States."/></extension><code value="V"/><display value="Schedule V"/></concept><concept ><extensionurl="http://hl7.org/fhir/StructureDefinition/codesystem-comments"><valueStringvalue="State defined"/></extension><code value="VI"/><display value="Schedule VI"/></concept></CodeSystem>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.

AltStyle によって変換されたページ (->オリジナル) /